Search results
Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.
Namita Thapar is an Indian entrepreneur. She is the Executive Director of Emcure Pharmaceuticals (as of 2022), an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra.
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.
20 hours ago · Namita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on Shark Tank, is set to earn approximately Rs 127 crore through the company's upcoming IPO. The issue ...
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . She has also been a prominent investor in Shark Tank India investing in over 100 companies.
Namita Thapar is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies.
Executive Director, India Business. Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, . Subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business.
2 days ago · 9.Emcure Pharmaceuticals Domestic Print: In the first six months ended September 30, 2023, and FY23, sales in India contributed 50.84 per cent and 53.16 per cent of the company's total revenue ...
Considering the upper price band of ₹ 1,008, the stake sale will fetch around ₹ 127 crore. As of March 2024, Thapar holds about 63 lakh shares or 3.5% in the company. The IPO comprises a fresh ...
Jan 6, 2023 · Jan 6, 2023 — 7 min read. Namita Thapar is a well-known figure, especially when it comes to progressive women in business in India. She is an inspiration and has contributed to the health business as Emcure Pharmaceuticals' Executive Director, India Business.
